Bloodstream infections caused by Enterococcus spp: A 10-year retrospective analysis at a tertiary hospital in China

  • Jin-xin Zheng (郑金鑫)
  • Hui Li (李 晖)
  • Zhang-ya Pu (蒲彰雅)
  • Hong-yan Wang (王红燕)
  • Xiang-bin Deng (邓向斌)
  • Xiao-jun Liu (刘晓军)
  • Qi-wen Deng (邓启文)
  • Zhi-jian Yu (余治健)
Article

Summary

In order to discover the risk factors for 30-day mortality in bloodstream infections (BSI) caused by Enterococcus spp. strains, we explored the clinical and therapeutic profile of patients with Enterococcus spp. BSI and the characteristics of this condition. A total of 64 patients with BSI caused by Enterococcus spp. who were treated in our hospital between 2006 and 2015 were included in the study. The clinical features of patients, microbiology, and 30-day mortality were collected from the electronic medical records database and analyzed. The results showed that there were 38 patients infected by Enterococcus faecalis (E. faecalis), 24 by Enterococcus faecium (E. faecium), 1 by Enterococcus casseliflavus (E. casseliflavus), and 1 by Enterococcus gallinarum (E. gallinarum). A Charlson comorbidity score ≥5, corticosteroid treatment, placement of catheters or other prosthetic devices and history of antibiotic use were found more frequently in E. faecium BSI patients than in E. faecalis patients (P=0.017, P=0.027, P=0.008 and P=0.027, respectively). Furthermore, the univariate and multivariate analysis showed that corticosteroid treatment (OR=17.385, P=0.008), hospital acquisition (OR=16.328, P=0.038), and vascular catheter infection (OR=14.788, P=0.025) were all independently associated with 30-day mortality. Our results indicate that E. faecalis and E. faecium are two different pathogens with unique microbiologic characteristics, which cause different clinical features in BSI, and the empiric antimicrobial treatments are paramount for patients with enterococcal BSI.

Key words

Enterococcus faecalis Enterococcus faecium bloodstream infections mortality risk factors 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Sghir A, Gramet G, Suau A, et al. Quantification of bacterial groups within human fecal flora by oligonucleotide probe hybridization. Appl Environ Microbiol, 2000,66(5):2263–2266CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Damborg P, Top J, Hendrickx AP, et al. Dogs are a reservoir of ampicillin-resistant Enterococcus faecium lineages associated with human infections. Appl Environ Microbiol, 2009,75(8):2360–2365CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Foulquié Moreno MR, Sarantinopoulos P, Tsakalidou E, et al. The role and application of enterococci in food and health. Int J Food Microbiol, 2006,106(1):1–24CrossRefPubMedGoogle Scholar
  4. 4.
    Fisher K, Phillips C. The ecology, epidemiology and virulence of Enterococcus. Microbiology, 2009,155(Pt 6):1749–1757CrossRefPubMedGoogle Scholar
  5. 5.
    Treitman AN, Yarnold PR, Warren J, et al. Emerging incidence of Enterococcus faecium among hospital isolates (1993 to 2002). J Clin Microbiol, 2005,43(1):462–463CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Bonten MJ, Willems RJ. Vancomycin-resistant Enterococcus–chronicle of a foretold problem. Nederlands Tijdschrift Voor Geneeskunde, 2012,156 (38):A5233PubMedGoogle Scholar
  7. 7.
    Kayser FH. Safety aspects of enterococci from the medical point of view. Int J Food Microbiol, 2003,88(2-3):255–262CrossRefPubMedGoogle Scholar
  8. 8.
    Bearman GM, Wenzel RP. Bacteremias: a leading cause of death. Arch Med Res, 2005,36(6):646–659CrossRefPubMedGoogle Scholar
  9. 9.
    Beekmann SE, Diekema DJ, Chapin KC, et al. Effects of rapid detection of bloodstream infections on length of hospitalization and hospital charges. J Clin Microbiol, 2003,41(7):3119–3125CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Worth LJ, Spelman T, Bull AL, et al. Central line-associated bloodstream infections in Australian intensive care units: Time-trends in infection rates, etiology, and antimicrobial resistance using a comprehensive Victorian surveillance program, 2009-2013. Am J Infect Control, 2015,43(8):848–852CrossRefPubMedGoogle Scholar
  11. 11.
    Butler AM, Olsen MA, Merz LR, et al. The attributable costs of enterococcal bloodstream infections in a non-surgical hospital cohort. Infect Control Hosp Epidemiol, 2010,31(1):28–35CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Billington EO, Phang SH, Gregson DB, et al. Incidence, risk factors, and outcomes for Enterococcus spp. blood stream infections: A population-based study. Int J Infect Dis, 2014, 26: 76–82PubMedGoogle Scholar
  13. 13.
    Marschall J, Piccirillo ML, Fraser VJ, et al. Catheter removal versus retention in the management of catheter-associated enterococcal bloodstream infections. Can J Infect Dis Med Microbiol, 2013,24(3):e83–e87PubMedPubMedCentralGoogle Scholar
  14. 14.
    Shi SH, Kong HS, Jia CK, et al. Coagulase-negative staphylococcus and Enterococcus as predominant pathogens in liver transplant recipients with Gram-positive coccal bacteremia. Chin Med J, 2010,123(15):1983–1988PubMedGoogle Scholar
  15. 15.
    Ye QF, Zhao J, Wan QQ, et al. Frequency and clinical outcomes of ESKAPE bacteremia in solid organ transplantation and the risk factors for mortality. Transpl Infect Dis, 2014,16(5):767–774CrossRefPubMedGoogle Scholar
  16. 16.
    Ouyang W, Li X, Wan Q, et al. The risk factors for mortality and septic shock in liver transplant recipients with ESKAPE bacteremia. Hepatogastroenterology, 2015, 62(138):346–349PubMedGoogle Scholar
  17. 17.
    Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis, 1987,40(5):373–383CrossRefPubMedGoogle Scholar
  18. 18.
    Le Gall JR, Lemeshow S, Saulnier F. A new simplified acute physiology score (SAPS II) based on a European/ North American multicenter study. JAMA, 1993,270(24):2957–2963CrossRefPubMedGoogle Scholar
  19. 19.
    Chen CK, Lin SC, Wu CC, et al. STARD-compliant article: The utility of red cell distribution width to predict mortality for septic patients visiting the emergency department. Medicine, 2016,95(24):e3692CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Picot-Guéraud R, Batailler P, Caspar Y, et al. Bacteremia caused by multidrug-resistant bacteria in a French university hospital center: 3 years of collection. Am J Infect Control, 2015,43(9):960–964CrossRefPubMedGoogle Scholar
  21. 21.
    Friedman ND, Kaye KS, Stout JE, et al. Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med, 2002,137(10):791–797CrossRefPubMedGoogle Scholar
  22. 22.
    Maki DG, Agger WA. Enterococcal bacteremia: clinical features, the risk of endocarditis, and management. Medicine, 1988,67(10):248–269CrossRefPubMedGoogle Scholar
  23. 23.
    Gray J, Marsh PJ, Stewart D, et al. Enterococcal bacteraemia: a prospective study of 125 episodes. J Hosp Infect, 1994,27(3):179–186CrossRefPubMedGoogle Scholar
  24. 24.
    McBride SJ, Upton A, Roberts SA. Clinical characteristics and outcomes of patients with vancomycin-susceptible Enterococcus faecalis and Enterococcus faecium bacteraemia—a five-year retrospective review. Eur J Clin Microbiol Infect Dis, 2010,29(1):107–114CrossRefPubMedGoogle Scholar
  25. 25.
    Ceci M, Delpech G, Sparo M, et al. Clinical and microbiological features of bacteremia caused by Enterococcus faecalis. J Infect Dev Ctries, 2015,9(11):1195–1203CrossRefPubMedGoogle Scholar
  26. 26.
    Lark RL, Chenoweth C, Saint S, et al. Four-year prospective evaluation of nosocomial bacteremia: epidemiology, microbiology, and patient outcome. Diagn Microbiol Infect Dis, 2000, 38(3):131–140CrossRefPubMedGoogle Scholar
  27. 27.
    Conde-Estévez D, Sorli L, Morales-Molina JA, et al. Differentiating clinical characteristics in bacteriemia caused by Enterococcus faecalis or Enterococcus faecium. Enferm Infecc Microbiol Clin, 2010,28(6):342–348CrossRefPubMedGoogle Scholar
  28. 28.
    Retamar P, López-Prieto MD, Rodríguez-López F, et al. Predictors of early mortality in very elderly patients with bacteremia: a prospective multicenter cohort. Int J Infect Dis, 2014, 26: 83–87CrossRefPubMedGoogle Scholar
  29. 29.
    Zasowski EJ, Claeys KC, Lagnf AM, et al. Time is of the essence: the impact of delayed antibiotic therapy on patient outcomes in hospital-onset Enterococcal bloodstream infections. Clin Infect Dis, 2016,62(10):1242–1250CrossRefPubMedGoogle Scholar
  30. 30.
    Zhao C, Chen H, Wang H, et al. Analysis of pathogen spectrum and resistance of clinical common organisms causing bloodstream infections, hospital-acquired pneumonia and intra-abdominal infections from thirteen teaching hospitals in 2013. Zhonghua Yi Xue Za Zhi (Chinese), 2015,95(22):1739–1746Google Scholar
  31. 31.
    Ortega M, Marco F, Soriano A, et al. Epidemiology and outcome of bacteraemia in neutropenic patients in a single institution from 1991-2012. Epidemiol Infect, 2015,143(4):734–740CrossRefPubMedGoogle Scholar
  32. 32.
    Forsblom E, Nurmi AM, Ruotsalainen E, et al. Should all adjunctive corticosteroid therapy be avoided in the management of hemodynamically stabile Staphylococcus aureus bacteremia? Eur J Clin Microbiol Infect Dis, 2016,35(3):471–479Google Scholar
  33. 33.
    Reigadas E, Rodríguez-Créixems M, Guembe M, et al. Catheter-related bloodstream infection caused by Enterococcus spp. Clin Microbiol Infect, 2013,19(5):457–461CrossRefPubMedGoogle Scholar

Copyright information

© Huazhong University of Science and Technology and Springer-Verlag Berlin Heidelberg 2017

Authors and Affiliations

  • Jin-xin Zheng (郑金鑫)
    • 1
  • Hui Li (李 晖)
    • 2
  • Zhang-ya Pu (蒲彰雅)
    • 1
  • Hong-yan Wang (王红燕)
    • 1
  • Xiang-bin Deng (邓向斌)
    • 1
  • Xiao-jun Liu (刘晓军)
    • 1
  • Qi-wen Deng (邓启文)
    • 1
  • Zhi-jian Yu (余治健)
    • 1
  1. 1.Department of Infectious Diseases and Shenzhen Key Lab for Endogenous Infection, Shenzhen Nanshan HospitalShenzhen UniversityShenzhenChina
  2. 2.Department of Gastroenterology, The Central Hospital of Wuhan, Tongji Medical CollegeHuazhong University of Science and TechnologyWuhanChina

Personalised recommendations